Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Chirovsky · SciRah

Researcher profile · Semantic Scholar

D. Chirovsky

Share profile

D. Chirovsky — researcher profile on SciRah

h-index: 14
Works: 55
Citations: 662

Most-cited papers

Renal function, health outcomes, and resource utilization in acute heart failure: a systematic review.
J. Butler, D. Chirovsky, H. Phatak, A. McNeill +1 more
2010Circulation: Heart Failure89 citations Open access
Semantic Scholar
Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review.
Mallika Lala, D. Chirovsky, Jonathan D. Cheng, K. Mayawala
2018Oral Oncology73 citations
Semantic Scholar
Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient’s perspective
I. Hirji, Shaloo Gupta, A. Goren, D. Chirovsky +4 more
2013Health and Quality of Life Outcomes55 citations Open access
Semantic Scholar
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Viktor Grünwald, D. Chirovsky, W. Cheung, F. Bertolini +11 more
2020Oral Oncology54 citations Open access
Semantic Scholar
Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review
D. Chirovsky, V. Fedirko, Ya-Dong Cui, V. Sazonov +1 more
2009European Journal of Cardiovascular Prevention & Rehabilitation54 citations
Semantic Scholar
Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data.
H. West, Xiaohan Hu, Su Zhang, Yan Song +6 more
2022Clinical Lung Cancer40 citations Open access
Semantic Scholar
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
D. Rischin, K. Harrington, R. Greil, D. Soulières +19 more
2022Oral Oncology39 citations Open access
Semantic Scholar
Quality of Life With Pembrolizumab for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
K. Harrington, D. Soulières, C. le Tourneau, J. Dinis +12 more
2020Journal of the National Cancer Institute27 citations Open access
Semantic Scholar
Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
Masoom Priyadarshini, V. Prabhu, S. Snedecor, S. Corman +4 more
2021Frontiers in Public Health22 citations Open access
Semantic Scholar
Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in the United States
Rebekah H. Borse, K. Ramakrishnan, J. Gandhi, Praveen Dhankhar +1 more
2022Journal of Medical Economics18 citations Open access
Semantic Scholar
Treatment patterns and outcomes among patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
E. Nadler, S. Joo, M. Boyd, J. Black-Shinn +1 more
2019Future Oncology17 citations
Semantic Scholar
Evaluation of disease-free survival as a predictor of overall survival and assessment of real-world burden of disease recurrence in resected early-stage non–small cell lung cancer
H. West, Xiaohan Hu, Su Zhang, Yan Song +6 more
2023Journal of Managed Care & Specialty Pharmacy15 citations Open access
Semantic Scholar
OA15.06 Pooled Analysis of Outcomes with Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
D. Rodríguez-Abreu, Y.-L. Wu, M. Boyer, M. Garassino +18 more
2022Journal of Thoracic Oncology15 citations Open access
Semantic Scholar
Health-related quality of life (HRQoL) of pembrolizumab (pembro) vs standard of care (SOC) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in KEYNOTE-040.
E. Cohen, D. Soulières, C. le Tourneau, J. Dinis +12 more
201815 citations
Semantic Scholar
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629
B. Hughes, R. G. Mendoza, N. Basset-Seguin, O. Vornicova +11 more
2021Dermatologic Therapy13 citations Open access
Semantic Scholar
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resection.
H. West, Xiaohan Hu, D. Chirovsky, M. Walker +4 more
2023Future Oncology12 citations Open access
Semantic Scholar
Cost-Effectiveness of Pembrolizumab Regimens for the First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma in Argentina
Victoria Wurcel, D. Chirovsky, Rebekah H. Borse, Juan Ignacio Altuna +2 more
2021Advances in Therapy12 citations Open access
Semantic Scholar
Utilization patterns of extended-release niacin in Canada: analysis of an administrative claims database.
M. Dorais, D. Chirovsky, B. Ambegaonkar, V. Sazonov +3 more
2010Canadian Journal of Cardiology12 citations Open access
Semantic Scholar
Assessing the Comparability of Paper and Electronic Versions of the EORTC QOL Module for Head and Neck Cancer: A Qualitative Study
J. Norquist, D. Chirovsky, Teja Munshi, C. Tolley +2 more
2017JMIR Cancer9 citations Open access
Semantic Scholar
Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis
C. Black, S. Keeping, A. Mojebi, K. Ramakrishnan +4 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
OA07.04 Overall Survival in Patients with Advanced NSCLC Receiving Taxane-Containing Regimen After Exposure to Immunotherapy and Platinum-Doublet
S. Liu, X. Hu, D. Chirovsky, W. Meng +1 more
2022Journal of Thoracic Oncology8 citations Open access
Semantic Scholar
Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinoma.
K. Ramakrishnan, Zhiwen Liu, S. Baxi, S. Chandwani +2 more
2021Future Oncology8 citations Open access
Semantic Scholar
Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
B. Ambegaonkar, L. Bash, D. Chirovsky, K. Jameson +4 more
2013European journal of internal medicine8 citations
Semantic Scholar
Attainment of Normal Lipid Levels Among Patients on Lipid-Modifying Therapy in Hong Kong
B. Ambegaonkar, D. Chirovsky, H. Tse, Yuk-Kong Lau +7 more
2012Advances in Therapy7 citations
Semantic Scholar
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040
K. Harrington, D. Soulières, C. le Tourneau, J. Dinis +12 more
20216 citations
Semantic Scholar
Global longitudinal assessment of treatment outcomes in recurrent/metastatic nasopharyngeal carcinoma: GLANCE-NPC study.
M. Ahn, D. Chirovsky, H. Kuyas, V. Auclair +4 more
2021Future Oncology5 citations Open access
Semantic Scholar
Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinoma.
Thao T. Vo, J. Espirito, M. Boyd, B. Gumuscu +5 more
2022Future Oncology4 citations
Semantic Scholar
Prevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapy.
D. Colquhoun, D. Chirovsky, V. Sazonov, Ya-Dong Cui +1 more
2013Experimental and Clinical Cardiology3 citations
Semantic Scholar
Corrigendum: Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
Masoom Priyadarshini, V. Prabhu, S. Snedecor, S. Corman +4 more
2021Frontiers in Public Health2 citations Open access
Semantic Scholar
PCN11 - GLOBAL LONGITUDINAL ASSESSMENT OF TREATMENT OUTCOMES IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (GLANCE-H&N) STUDY
V. Gruenwald, D. Chirovsky, W. Cheung, F. Bertolini +10 more
2018Value in Health2 citations Open access
Semantic Scholar
Inpatient Treatment Patterns and Health Care Expenditures for Hepatocellular Carcinoma among the Population with Urban Basic Health Insurance in China.
F. Du, D. Chirovsky, X. Xiong, Jing-Hu Li +3 more
2015Value in Health Regional Issues2 citations Open access
Semantic Scholar
The Effects of Isolated versus Multiple Lipid Disorders on Resource Utilization among Metabolic Syndrome Patients with Lipid Abnormalities despite Lipid-Modifying Treatment
B. Ambegaonkar, D. Chirovsky, W. Wu, H. Colclough +2 more
2010The Cardiology2 citations
Semantic Scholar
HSR23-117: First-Line (1L) Systemic Therapy in Patients (pts) With Advanced Non–Small Cell Lung Cancer (aNSCLC) at Community Settings in the United States (US)
Stephen V. Liu, Pragya Rai, Yu-Han Kao, D. Chirovsky +1 more
2023The Journal of the National Comprehensive Cancer Network1 citations
Semantic Scholar
Network meta-analysis (NMA) of pembrolizumab for first-line (1L) treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
K. Ramakrishnan, A. Mojebi, D. Ayers, D. Chirovsky +2 more
20211 citations
Semantic Scholar
Health-Related Quality of Life of Pembrolizumab for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma in KEYNOTE-629
B. Hughes, R. Gonzalez, N. Basset-Seguin, O. Vornicova +11 more
20201 citations
Semantic Scholar
PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous CELL Carcinoma in Patients Whose Tumor Expressed Programmed Death-Ligand 1 at Combined Positive Score ≥1 in France
M. Massetti, C. Even, L. Geoffrois, G. Farge +4 more
20201 citations Open access
Semantic Scholar
Programmed death-ligand 1 (PD-L1) expression and HPV-associated p16 in oropharyngeal squamous cell carcinoma (OSCC) treated with primary curative radiotherapy (RT).
T. Steiniche, J. G. Eriksen, J. Lilja-Fischer, J. Georgsen +7 more
2018Annals of Oncology1 citations Open access
Semantic Scholar
Patient Preferences for Chronic Myeloid Leukemia Medication Regimen Attributes and their Potential Impact on Adherence: Results from a Multi-national Conjoint Study
I. Hirji, J. Grinspan, E. Flood, D. Chirovsky +3 more
2014Journal of health economics and outcomes research1 citations Open access
Semantic Scholar
Attainment of goal and normalized lipid levels with lipid-modifying therapy in Malaysia.
T. Hsu, D. Chirovsky, F. Moy, B. Ambegaonkar
2013Clinical Therapeutics1 citations
Semantic Scholar
95P Neoadjuvant treatment pattern and association between real-world event-free survival (rwEFS) and overall survival (OS) in patients (pts) with resected early-stage non-small cell lung cancer (eNSCLC)
J. Donington, X. Hu, S. Zhang, Y. Song +7 more
2023Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP08.01-083 Real-World PD-(L)1 Inhibitor Treatment Pattern and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden
G. Wagenius, A. Vikström, A. Berglund, S. Salomonsson +5 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP02.03-009 Real-world Disease-Free Survival as a Predictor of Overall Survival in Resected Early-Stage Non-Small Cell Lung Cancer
H. West, X. Hu, D. Chirovsky, Y. Song +6 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Cost-effectiveness (CE) analysis of pembrolizumab as first-line (1L) treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the United States (US).
K. Ramakrishnan, Disha Jain, J. Gandhi, D. Chirovsky +1 more
20210 citations
Semantic Scholar
872P Association between event-free (EFS) and overall survival (OS) in newly diagnosed patients (pts) with locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
C. Black, S. Keeping, D. Chirovsky, K. Ramakrishnan +3 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
Real-world (RW) systemic treatment patterns and clinical outcomes in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) patients (pts).
Thao T. Vo, M. Boyd, J. Espirito, B. Gumuscu +5 more
20200 citations
Semantic Scholar
271P Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Taiwan
C.-H. Wang, Harry H. Lei, R. Borse, D. Chirovsky +3 more
20200 citations Open access
Semantic Scholar
Real World Treatment Patterns and Time On Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Previously Treated with Platinum-Containing Chemotherapy in United States (US)
D. Chirovsky, Z. Liu, S. Baxi, S. Chandwani +2 more
20200 citations
Semantic Scholar
Global longitudinal assessment of treatment outcomes in nasopharyngeal carcinoma (GLANCE-NPC) study
M. Ahn, D. Chirovsky, H. Kuyas, V. Auclair +4 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
Bealth Care Resource Utilization (HCRU) of Head and Neck Cancers (HNC) in Hungary: A Retrospective Cross-Sectional Analysis of the National Healthcare Services Center Database in 2010-2016
A. Szücs, T. Kováts, A. Brandtmüller, D. Chirovsky +2 more
20180 citations Open access
Semantic Scholar
Treatment patterns in recurrent/metastatic head and neck squamous cell carcinoma in the US.
E. Nadler, S. Joo, J. Black-Shinn, M. Boyd +2 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Swaby×8
Invite
R. Swaby — researcher profile on SciRah
M. Ahn×7
Invite
M. Ahn — researcher profile on SciRah
K. Ramakrishnan×7
Invite
K. Ramakrishnan — researcher profile on SciRah
S. Joo×6
Invite
S. Joo — researcher profile on SciRah

×6

Invite

B. Ambegaonkar — researcher profile on SciRah

K. Harrington×5

Invite

K. Harrington — researcher profile on SciRah

Invite

V. Sazonov — researcher profile on SciRah

Jonathan D. Cheng×4

Invite

Jonathan D. Cheng — researcher profile on SciRah

Invite

H. Kuyas — researcher profile on SciRah

Invite

V. Auclair — researcher profile on SciRah

J. Signorovitch×4

Invite

J. Signorovitch — researcher profile on SciRah

D. Soulières×4

Invite

D. Soulières — researcher profile on SciRah